Schedule 13G Filing for EDESA BIOTECH, INC.

2026-03-16SEC Filing SCHEDULE 13G (0001193125-26-108289)

Perceptive Advisors LLC, along with Joseph Edelman and the Master Fund, has reported acquiring a 6.7% stake in EDESA BIOTECH, INC. This holding amounts to 563,239 shares. The filing, dated March 16, 2026, with an event date of March 9, 2026, indicates that these securities were not acquired for the purpose of influencing control of the issuer. Perceptive Advisors acts as the investment manager for the Master Fund, and Joseph Edelman is the managing member of Perceptive Advisors. The ownership is based on 8,348,161 outstanding shares as of February 12, 2026.

Ticker mentioned:EDSAInstitution mentioned:PERCEPTIVE ADVISORS LLC
Related industry:Biotechnology